Berk P, II, Hoogerbrugge N, Stolk RP, Bootsma AH, Jansen H (2003)
Atorvastatin dose-dependently decreases hepatic lipase activity in type 2 diabetes: effect of sex and the LIPC promoter variant
Diabetes Care 26: 427